Verona Pharma plc (VRNA) Fell -39.0% or -3.9 To Price $6.1 On Monday

Verona Pharma plc (VRNA) fell -39.0% or -3.9 to $6.1. It is around 36697 shares traded, which is 1152.91% compare to the average total volume 3183. The market cap of VRNA is $80.31 million. The year to date change is -35.37%. The 52 week price range is from $5.65 to $25.55. Price of VRNA have changed 7.85% during last week. It have changed -9.00% over last month, -17.83% over last 3 months, -28.32% over last 6 months and -19.37% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VRNA is 10.75. It is 76.23% above current price. The 200-day Moving Averages for VRNA is 13.73. It is 125.08% above current price. The 52-week High is 25.55. It is 318.85% from the current price. The 52-week Low is 5.65. It is -7.38% from current price.

There are some statistics of VRNA. It is has market cap $80.31 million. The share outstanding is 13.17 million. The average volume is 3183. The percent of top 15 Institution holding is 57.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VRNA is -30.39%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VRNA is -26.65%.


Share this post